Panagora Asset Management’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-27,529
| Closed | -$1.94M | – | 1152 |
|
|
2024
Q3 | $1.94M | Buy |
27,529
+13,474
| +96% | +$1.13M | 0.01% | 543 |
|
|
2024
Q2 | $1.16M | Sell |
14,055
-3,802
| -21% | -$317K | 0.01% | 677 |
|
|
2024
Q1 | $1.56M | Sell |
17,857
-8,561
| -32% | -$766K | 0.01% | 655 |
|
|
2023
Q4 | $2.55M | Buy |
26,418
+1,173
| +5% | +$104K | 0.01% | 489 |
|
|
2023
Q3 | $2.23M | Buy |
25,245
+7,967
| +46% | +$709K | 0.01% | 487 |
|
|
2023
Q2 | $1.5M | Sell |
17,278
-17,922
| -51% | -$1.69M | 0.01% | 651 |
|
|
2023
Q1 | $3.42M | Buy |
35,200
+17,719
| +101% | +$1.84M | 0.02% | 444 |
|
|
2022
Q4 | $1.81M | Sell |
17,481
-3,915
| -18% | -$368K | 0.01% | 663 |
|
|
2022
Q3 | $1.81M | Buy |
21,396
+8,786
| +70% | +$782K | 0.01% | 631 |
|
|
2022
Q2 | $1.04M | Buy |
12,610
+2,361
| +23% | +$188K | 0.01% | 861 |
|
|
2022
Q1 | $790K | Sell |
10,249
-212
| -2% | -$17.7K | ﹤0.01% | 1036 |
|
|
2021
Q4 | $924K | Sell |
10,461
-1,513
| -13% | -$125K | ﹤0.01% | 958 |
|
|
2021
Q3 | $925K | Sell |
11,974
-141
| -1% | -$11.1K | ﹤0.01% | 996 |
|
|
2021
Q2 | $1.01M | Sell |
12,115
-580
| -5% | -$46K | 0.01% | 982 |
|
|
2021
Q1 | $959K | Buy |
12,695
+1,331
| +12% | +$109K | 0.01% | 1037 |
|
|
2020
Q4 | $996K | Buy |
11,364
+2,930
| +35% | +$232K | 0.01% | 968 |
|
|
2020
Q3 | $642K | Buy |
8,434
+5,262
| +166% | +$532K | ﹤0.01% | 1069 |
|
|
2020
Q2 | $391K | Buy |
3,172
+157
| +5% | +$15.6K | ﹤0.01% | 1291 |
|
|
2020
Q1 | $255K | Hold |
3,015
| – | – | ﹤0.01% | 1380 |
|
|
2019
Q4 | $255K | Buy |
3,015
+415
| +16% | +$31.3K | ﹤0.01% | 1526 |
|
|
2019
Q3 | $175K | Sell |
2,600
-1,830
| -41% | -$141K | ﹤0.01% | 1667 |
|
|
2019
Q2 | $379K | Sell |
4,430
-136
| -3% | -$11.6K | ﹤0.01% | 1534 |
|
|
2019
Q1 | $406K | Hold |
4,566
| – | – | ﹤0.01% | 1460 |
|
|
2018
Q4 | $389K | Hold |
4,566
| – | – | ﹤0.01% | 1401 |
|
|
2018
Q3 | $443K | Hold |
4,566
| – | – | ﹤0.01% | 1411 |
|
|
2018
Q2 | $430K | Hold |
4,566
| – | – | ﹤0.01% | 1424 |
|
|
2018
Q1 | $370K | Sell |
4,566
-615
| -12% | -$52.8K | ﹤0.01% | 1477 |
|
|
2017
Q4 | $462K | Sell |
5,181
-666
| -11% | -$57.9K | ﹤0.01% | 1400 |
|
|
2017
Q3 | $544K | Buy |
5,847
+1,281
| +28% | +$113K | ﹤0.01% | 1328 |
|
|
2017
Q2 | $415K | Hold |
4,566
| – | – | ﹤0.01% | 1406 |
|
|
2017
Q1 | $401K | Hold |
4,566
| – | – | ﹤0.01% | 1434 |
|
|
2016
Q4 | $378K | Buy |
4,566
+445
| +11% | +$38.3K | ﹤0.01% | 1541 |
|
|
2016
Q3 | $381K | Hold |
4,121
| – | – | ﹤0.01% | 1542 |
|
|
2016
Q2 | $321K | Sell |
4,121
-766
| -16% | -$65.1K | ﹤0.01% | 1511 |
|
|
2016
Q1 | $403K | Buy |
4,887
+1,185
| +32% | +$96.4K | ﹤0.01% | 1417 |
|
|
2015
Q4 | $388K | Sell |
3,702
-6,217
| -63% | -$649K | ﹤0.01% | 1398 |
|
|
2015
Q3 | $1.04M | Sell |
9,919
-1,348
| -12% | -$180K | 0.01% | 1023 |
|
|
2015
Q2 | $1.54M | Buy |
11,267
+6,045
| +116% | +$749K | 0.01% | 912 |
|
|
2015
Q1 | $651K | Buy |
5,222
+1,044
| +25% | +$111K | ﹤0.01% | 1218 |
|
|
2014
Q4 | $378K | Buy |
4,178
+1,378
| +49% | +$115K | ﹤0.01% | 1390 |
|
|
2014
Q3 | $202K | Hold |
2,800
| – | – | ﹤0.01% | 1629 |
|
|
2014
Q2 | $174K | Hold |
2,800
| – | – | ﹤0.01% | 1761 |
|
|
2014
Q1 | $191K | Buy |
2,800
+200
| +8% | +$14.7K | ﹤0.01% | 1758 |
|
|
2013
Q4 | $183K | Sell |
2,600
-11,339
| -81% | -$770K | ﹤0.01% | 1700 |
|
|
2013
Q3 | $1.01M | Buy |
13,939
+740
| +6% | +$49.2K | ﹤0.01% | 1112 |
|
|
2013
Q2 | $736K | Buy |
+13,199
| New | +$823K | ﹤0.01% | 1180 |
|
Other funds holding BMRN
EIM